Robert A. Fildes
Vorsitzender bei Twinstrand Therapeutics, Inc.
Profil
Robert A.
Fildes currently works at Twinstrand Therapeutics, Inc., as Chairman and SB2, Inc., as President from 1998.
Dr. Fildes also formerly worked at Atlantic Technology Ventures, Inc., as Chief Executive Officer in 1998, Cetus Corp., as President & Chief Executive Officer, Scotgen Biopharmaceuticals, Inc., as Chairman & Chief Executive Officer from 1993 to 1997, La Jolla Pharmaceutical Co., as Chairman from 2011 to 2012, Inimex Pharmaceuticals, Inc., as Chairman, Anteo Technologies Pty Ltd., as Director from 2002 to 2003, Biogen MA, Inc., as President from 1980 to 1982, and Bristol Myers Squibb Co., as Vice President-Operations from 1975 to 1980.
Dr. Fildes received his undergraduate degree and doctorate degree from the University of London.
Aktive Positionen von Robert A. Fildes
| Unternehmen | Position | Beginn |
|---|---|---|
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Vorsitzender | - |
SB2, Inc.
 SB2, Inc. RestaurantsConsumer Services SB2, Inc. is a law firm based in Princeton, WI that specializes in providing support, representation, and services related to Medicare/Medicaid eligibility and reimbursement. The private company offers policies and procedures to promote consistent and effective methods of addressing eligibility issues at the facility level. The company also challenges adverse reimbursement decisions made by state agencies, MCOs, and Medicare contractors. SB2's team of lawyers helps clients make the most of their businesses by providing easier and more efficient access to Medicaid and Medicare, regardless of their size. | Präsident | 01.01.1998 |
Ehemalige bekannte Positionen von Robert A. Fildes
| Unternehmen | Position | Ende |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Vorsitzender | 19.01.2012 |
Anteo Technologies Pty Ltd.
 Anteo Technologies Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Anteo Technologies Pty Ltd. develops and designs a platform for the biotechnology. It offers LUMINEX platform, bio sensor applications, particle coupling and streptavidin products. The company was founded by Joe Maeji and is headquartered in Eight Mile Plains, Australia. | Direktor/Vorstandsmitglied | 01.04.2003 |
| Atlantic Technology Ventures, Inc. | Vorstandsvorsitzender | 01.12.1998 |
| Scotgen Biopharmaceuticals, Inc. | Vorstandsvorsitzender | 01.01.1997 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Präsident | 01.01.1982 |
Ausbildung von Robert A. Fildes
| University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 9 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Health Technology |
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
SB2, Inc.
SB2, Inc. RestaurantsConsumer Services SB2, Inc. is a law firm based in Princeton, WI that specializes in providing support, representation, and services related to Medicare/Medicaid eligibility and reimbursement. The private company offers policies and procedures to promote consistent and effective methods of addressing eligibility issues at the facility level. The company also challenges adverse reimbursement decisions made by state agencies, MCOs, and Medicare contractors. SB2's team of lawyers helps clients make the most of their businesses by providing easier and more efficient access to Medicaid and Medicare, regardless of their size. | Consumer Services |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
| Atlantic Technology Ventures, Inc. | Finance |
| Cetus Corp. | Health Technology |
| Scotgen Biopharmaceuticals, Inc. | |
Anteo Technologies Pty Ltd.
Anteo Technologies Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Anteo Technologies Pty Ltd. develops and designs a platform for the biotechnology. It offers LUMINEX platform, bio sensor applications, particle coupling and streptavidin products. The company was founded by Joe Maeji and is headquartered in Eight Mile Plains, Australia. | Commercial Services |